Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
This also boosted my libido I have been using injectables for a few years and the service, speed and quality is by far the best at Vitastar
The cancellation process A few reviewers describe difficulty canceling their subscription
Additional research on medial collateral ligament and quadriceps muscle detachment models has produced similar signatures accelerated repair timelines, improved tissue quality on histology, and functional endpoint improvements
provides strong antioxidant benefits
It's still moving through the Phase 3 TRIUMPH trial program, with an FDA decision not expected until roughly late 2027, so no clinic can legally prescribe it for weight loss today
